Clinical Trial

The Value of Cardiovascular Imaging in Kawasaki Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to assess the cardiovascular injury of Kawasaki disease with multi-modal imaging combined with clinical data. During their disease progress, participants will undergo cardiovascular magnetic resonance, echocardiography, electrocardiography, laboratory tests, and genetic tests when hospitalization and follow-up, and the baseline data will be collected at the admission. Some patients will undergo coronary computed tomography angiography (CCTA) or DSA due to the disease progress. All the above examination data and changes will be analyzed to assess the value of cardiovascular imaging in the pathogenesis, diagnosis, and prognosis of Kawasaki disease.
Trial Details
NCT Number NCT06641817
Lead Sponsor West China Second University Hospital
Conditions Kawasaki Disease
Enrollment 500 participants
Start Date 2023-09-01
Primary Completion 2033-01-01 (estimated)
Study Completion 2033-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-15